X-16698965-T-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_175859.3(CTPS2):āc.295A>Cā(p.Asn99His) variant causes a missense change. The variant allele was found at a frequency of 0.0000101 in 1,088,150 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: not found (cov: 23)
Exomes š: 0.000010 ( 0 hom. 4 hem. )
Consequence
CTPS2
NM_175859.3 missense
NM_175859.3 missense
Scores
2
5
10
Clinical Significance
Conservation
PhyloP100: 5.96
Genes affected
CTPS2 (HGNC:2520): (CTP synthase 2) The protein encoded by this gene catalyzes the formation of CTP from UTP with the concomitant deamination of glutamine to glutamate. This protein is the rate-limiting enzyme in the synthesis of cytosine nucleotides, which play an important role in various metabolic processes and provide the precursors necessary for the synthesis of RNA and DNA. Cancer cells that exhibit increased cell proliferation also exhibit an increased activity of this encoded protein. Thus, this protein is an attractive target for selective chemotherapy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.27255833).
BS2
High Hemizygotes in GnomAdExome4 at 4 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CTPS2 | NM_175859.3 | c.295A>C | p.Asn99His | missense_variant | 3/19 | ENST00000359276.9 | NP_787055.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CTPS2 | ENST00000359276.9 | c.295A>C | p.Asn99His | missense_variant | 3/19 | 1 | NM_175859.3 | ENSP00000352222.4 | ||
CTPS2 | ENST00000380241.7 | c.295A>C | p.Asn99His | missense_variant | 3/19 | 1 | ENSP00000369590.3 | |||
CTPS2 | ENST00000443824.5 | c.295A>C | p.Asn99His | missense_variant | 3/19 | 2 | ENSP00000401264.1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 genomes
Cov.:
23
GnomAD3 exomes AF: 0.0000467 AC: 8AN: 171308Hom.: 0 AF XY: 0.0000525 AC XY: 3AN XY: 57178
GnomAD3 exomes
AF:
AC:
8
AN:
171308
Hom.:
AF XY:
AC XY:
3
AN XY:
57178
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000101 AC: 11AN: 1088150Hom.: 0 Cov.: 27 AF XY: 0.0000113 AC XY: 4AN XY: 354686
GnomAD4 exome
AF:
AC:
11
AN:
1088150
Hom.:
Cov.:
27
AF XY:
AC XY:
4
AN XY:
354686
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 23
GnomAD4 genome
Cov.:
23
ExAC
AF:
AC:
11
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 07, 2023 | The c.295A>C (p.N99H) alteration is located in exon 3 (coding exon 2) of the CTPS2 gene. This alteration results from a A to C substitution at nucleotide position 295, causing the asparagine (N) at amino acid position 99 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;T
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D;.;.
M_CAP
Benign
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M;M;M
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Uncertain
D;D;D
Sift4G
Uncertain
D;D;D
Polyphen
P;P;P
Vest4
MutPred
Gain of catalytic residue at K100 (P = 0.059);Gain of catalytic residue at K100 (P = 0.059);Gain of catalytic residue at K100 (P = 0.059);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at